Zentraxa

📍 Bristol, United Kingdom🗓 Founded 2017👥 13 employees💰 Last funded Jan 2022
Biotechnology Research🌐 zentraxa.com
Website LinkedIn
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent the previously existing bio-design limits of conventional peptide synthesis with one universal process.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Zentraxa?
Zentraxa has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Zentraxa last raise funding?
The most recent investment in Zentraxa recorded on gritt.io was in January 2022.
When was Zentraxa founded?
Zentraxa was founded in 2017.
What industry is Zentraxa in?
Zentraxa operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Zentraxa based?
Zentraxa is headquartered in Bristol, United Kingdom.